Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in the preparation of active pharmaceutical ingredients (APIs) targeting tyrosine kinase receptors, which play a role in tumor growth and progression. Its structure allows for selective modification, enabling optimization of drug potency and bioavailability. Also employed in research settings for the design of novel bioactive molecules and in medicinal chemistry for structure-activity relationship (SAR) studies.